Investigadores de la UPM han probado que disminuye a la mitad el riesgo de desgarros perineales, reduce en un 13 por ciento el riesgo de cesárea y hasta en un 21% el riesgo de macrosomías, entre otr...
Read moreInvestigadores de la UPM trabajan en el desarrollo de nuevos fármacos que permitan evitar la recaída y mejoren la respuesta de los pacientes al tratamiento con quimioterapia.
Read moreLa Universidad de Cádiz logra un sustituto sostenible y más barato que el componente habitualmente empleado en la formación del tejido óseo
Read moreLas moléculas de RNA pequeño no codificante, junto con los métodos tradicionales, tienen potencial para mejorar la predicción del Alzheimer y su diagnóstico precoz
Read moreLa red Andalucía-Biotec Salud impulsará la armonización de biodatos, los biomodelos de enfermedades humanas y las plataformas de análisis a nivel de célula única
Read moreIt has been developed a urination device for women in supine decubitus (lying face up), which facilitates the flow of fluid outwards and prevents spillage. The new invention is aimed at industries tha...
Read moreAn international team of researchers identifies the genetic basis and biological processes that influence cancer risk related to alterations in the number of immune cells present in blood. This is a s...
Read moreA new project – FLAVIVACCINE – aims to increase the EU's ability to combat epidemic and pandemic viral threats both in Europe and around the world.
Read moreThe recent study, published in the journal Cell Host & Microbe, has elucidated the evolutionary trajectory of H3N2 influenza viruses, providing insights into specific receptor interactions and antigen...
Read moreScientific evidence shows that women are more likely to experience less characteristic combinations of symptoms, and that this influences the diagnostic process and the consequences of the disease.
Read moreBased on a study by IrsiCaixa and BSC, researchers have developed a new algorithm to enhance precision in selecting molecules, called neoantigens, that induce effective immune responses against cancer...
Read moreResults of the first-in-human phase I trial of OMO-103 demonstrate its safety and promising anti-tumor activity and shows how this MYC inhibitor can stabilize or even reduce disease burden in some hea...
Read more